Fouad Chebib, Mayo Clinic, Florida, USA Dr. Fouad Chebib, a nephrologist and physician-scientist at the Mayo Clinic, focuses on polycystic kidney disease (PKD), a complex genetic condition with significant variability among patients, even within families. His vision for precision medicine involves integrating diverse data—imaging, genetics, clinical data, and more—to create personalized predictions and treatments for each patient based on their unique disease trajectory. He emphasized the importance of collaboration between academia and the pharmaceutical industry to accelerate the development of therapies. His team is working on predictive models to identify high-risk patients and validate the efficacy of new treatments within short clinical trial timelines. Dr. Chebib highlighted two major challenges: the need for larger, more diverse datasets through international collaboration and the regulatory hurdles surrounding data sharing. He advocates for innovative approaches, such as federated learning, to overcome these obstacles while ensuring data security. Finally, he praised multidisciplinary events for fostering collaboration, inspiration, and new perspectives across fields, ultimately driving advancements in precision medicine.

For more information, please visit : https://www.p2m-symposium.com/

Hosted on Acast. See acast.com/privacy for more information.